Literature DB >> 25217811

Increased activity of the complement system in the liver of patients with alcoholic hepatitis.

Hong Shen1, Barbara A French2, Hui Liu2, Brittany C Tillman2, Samuel W French3.   

Abstract

Inflammation has been suggested as a mechanism underlying the development of alcoholic hepatitis (AH). The activation of the complement system plays an important role in inflammation. Although it has been shown that ethanol-induced activation of the complement system contributes to the pathophysiology of ethanol-induced liver injury in mice, whether ethanol consumption activates the complement system in the human liver has not been investigated. Using antibodies against C1q, C3, and C5, the immunoreactivity of the complement system in patients with AH was examined by immunohistochemistry and quantified by morphometric image analysis. The immunoreactivity intensity of C1q, C3, and C5 in patients with AH was significantly higher than that seen in normal controls. Further, the gene expression of C1q, C3, and C5 was examined using real-time PCR. There were increases in the levels of C1q and C5, but not C3 mRNA in AH. Moreover, the immunoreactivity of C5a receptor (C5aR) also increased in AH. To explore the functional implication of the activation of the complement system in AH, we examined the colocalization of C5aR in Mallory-Denk bodies (MDBs) forming balloon hepatocytes. C5aR was focally overexpressed in the MDB forming cells. Collectively, our study suggests that alcohol consumption increases the activity of the complement system in the liver cells, which contributes to the inflammation-associated pathogenesis of AH.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcoholic hepatitis; Complement factors; Inflammation; Mallory–Denk bodies

Mesh:

Substances:

Year:  2014        PMID: 25217811      PMCID: PMC4262612          DOI: 10.1016/j.yexmp.2014.09.004

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  35 in total

Review 1.  Liver: An organ with predominant innate immunity.

Authors:  Bin Gao; Won-Il Jeong; Zhigang Tian
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

2.  Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans.

Authors:  Sonja Hillebrandt; Hermann E Wasmuth; Ralf Weiskirchen; Claus Hellerbrand; Hildegard Keppeler; Alexa Werth; Ramin Schirin-Sokhan; Gabriele Wilkens; Andreas Geier; Johann Lorenzen; Jörg Köhl; Axel M Gressner; Siegfried Matern; Frank Lammert
Journal:  Nat Genet       Date:  2005-07-03       Impact factor: 38.330

Review 3.  The complement system in liver diseases.

Authors:  Xuebin Qin; Bin Gao
Journal:  Cell Mol Immunol       Date:  2006-10       Impact factor: 11.530

4.  Activated complement factor 3 is associated with liver fat and liver enzymes: the CODAM study.

Authors:  Nick Wlazlo; Marleen M J van Greevenbroek; Isabel Ferreira; Eugene H J M Jansen; Edith J M Feskens; Carla J H van der Kallen; Casper G Schalkwijk; Bert Bravenboer; Coen D A Stehouwer
Journal:  Eur J Clin Invest       Date:  2013-04-16       Impact factor: 4.686

5.  TLR3/4 signaling is mediated via the NFκB-CXCR4/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory-Denk bodies.

Authors:  Hui Liu; Jun Li; Brittany Tillman; Timothy R Morgan; Barbara A French; Samuel W French
Journal:  Exp Mol Pathol       Date:  2014-07-02       Impact factor: 3.362

Review 6.  A key role of C5a/C5aR activation for the development of sepsis.

Authors:  Niels C Riedemann; Ren-Feng Guo; Peter A Ward
Journal:  J Leukoc Biol       Date:  2003-08-01       Impact factor: 4.962

7.  The third (C3) and fourth (C4) components of complement in human liver. Immunocytochemical evidence for hepatocytes as the site of synthesis.

Authors:  H Nagura; H Hasegawa; S Yoshimura; K Watanabe
Journal:  Acta Pathol Jpn       Date:  1985-01

8.  Epigenetics of proteasome inhibition in the liver of rats fed ethanol chronically.

Authors:  Joan Oliva; Jennifer Dedes; Jun Li; Samuel-W French; Fawzia Bardag-Gorce
Journal:  World J Gastroenterol       Date:  2009-02-14       Impact factor: 5.742

9.  Activation of the complement system in human nonalcoholic fatty liver disease.

Authors:  Sander S Rensen; Yanti Slaats; Ann Driessen; Carine J Peutz-Kootstra; Jeroen Nijhuis; Rudi Steffensen; Jan Willem Greve; Wim A Buurman
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

Review 10.  Broad spectrum of hepatocyte inclusions in humans, animals, and experimental models.

Authors:  Pavel Strnad; Renwar Nuraldeen; Nurdan Guldiken; Daniel Hartmann; Vineet Mahajan; Helmut Denk; Johannes Haybaeck
Journal:  Compr Physiol       Date:  2013-10       Impact factor: 9.090

View more
  12 in total

1.  Complement factor H-deficient mice develop spontaneous hepatic tumors.

Authors:  Jennifer Laskowski; Brandon Renner; Matthew C Pickering; Natalie J Serkova; Peter M Smith-Jones; Eric T Clambey; Raphael A Nemenoff; Joshua M Thurman
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

2.  Soluble IgM links apoptosis to complement activation in early alcoholic liver disease in mice.

Authors:  Rebecca L Smathers; Dian J Chiang; Megan R McMullen; Ariel E Feldstein; Sanjoy Roychowdhury; Laura E Nagy
Journal:  Mol Immunol       Date:  2016-02-27       Impact factor: 4.407

3.  Complement Factor D protects mice from ethanol-induced inflammation and liver injury.

Authors:  Rebecca L McCullough; Megan R McMullen; Megan M Sheehan; Kyle L Poulsen; Sanjoy Roychowdhury; Dian J Chiang; Michele T Pritchard; Juan Caballeria; Laura E Nagy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-29       Impact factor: 4.052

Review 4.  Liver cirrhosis and immune dysfunction.

Authors:  Elda Hasa; Phillipp Hartmann; Bernd Schnabl
Journal:  Int Immunol       Date:  2022-09-06       Impact factor: 5.071

Review 5.  New treatment options for alcoholic hepatitis.

Authors:  Saggere Muralikrishna Shasthry; Shiv Kumar Sarin
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

6.  Increased DNA methylation in the livers of patients with alcoholic hepatitis.

Authors:  Hong Shen; Barbara A French; Brittany C Tillman; Jun Li; Samuel W French
Journal:  Exp Mol Pathol       Date:  2015-08-08       Impact factor: 3.362

7.  Differential contribution of complement receptor C5aR in myeloid and non-myeloid cells in chronic ethanol-induced liver injury in mice.

Authors:  Rebecca L McCullough; Megan R McMullen; Dola Das; Sanjoy Roychowdhury; Michael G Strainic; M Edward Medof; Laura E Nagy
Journal:  Mol Immunol       Date:  2016-06-06       Impact factor: 4.407

Review 8.  Inflammatory status in human hepatic cirrhosis.

Authors:  María Martínez-Esparza; María Tristán-Manzano; Antonio J Ruiz-Alcaraz; Pilar García-Peñarrubia
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

9.  Diagnostic and Prognostic Significance of Complement in Patients With Alcohol-Associated Hepatitis.

Authors:  Xiude Fan; Rebecca L McCullough; Emily Huang; Annette Bellar; Adam Kim; Kyle L Poulsen; Craig J McClain; Mack Mitchell; Arthur J McCullough; Svetlana Radaeva; Bruce Barton; Gyongyi Szabo; Srinivasan Dasarathy; Daniel M Rotroff; Laura E Nagy
Journal:  Hepatology       Date:  2020-11-22       Impact factor: 17.425

Review 10.  Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis.

Authors:  Cheng-Jie Lin; Zhi-Gao Hu; Guan-Dou Yuan; Biao Lei; Song-Qing He
Journal:  World J Hepatol       Date:  2018-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.